Black kids die more often after surgery, new research shows
AP Medical Writer | Hagadone News Network | UPDATED 5 years, 4 months AGO
Black children were more likely than whites to die after common surgeries, a U.S. study found, echoing evidence seen in adults.
The researchers examined national data on nearly 173,000 operations from 2012 through 2017. Appendix removal and orthopedic operations were among the most common surgeries. And while there were few deaths, the disparities were striking: 23 black youngsters died within 30 days of surgery compared with 13 whites.
The study was published Monday in Pediatrics.
Children were younger than 17 and were considered relatively healthy before their surgeries. While Black children had slightly more heart and digestive problems, pre-existing conditions were uncommon.
Those differences don’t fully explain the results, said lead author, Dr. Olubukola Nafiu of Nationwide Children’s Hospital in Columbus, Ohio.
Differences in hospital quality and doctor bias have been suggested as contributors to racial health inequities in other research, but Nafiu said those factors are beyond the study's scope and that reasons for the disparities found are uncertain.
A editorial in Pediatrics says the research sheds new light on a concerning problem and should prompt doctors and hospitals to confront their own biases.
It cites a previous study showing that doctors “with greater implicit bias” were more likely to prescribe narcotic medications for post-surgery pain for white children than for Blacks. And other research has found that doctors often underestimate pain in Black patients.
___
Follow AP Medical Writer Lindsey Tanner on Twitter: @LindseyTanner
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
ARTICLES BY AP MEDICAL WRITER
Key events in development of Pfizer's COVID-19 vaccine
Key events in the development of a COVID-19 vaccine by partners Pfizer Inc. and Germany's BioNTech:
Key events in development of Pfizer's COVID-19 vaccine
Key events in the development of a COVID-19 vaccine by partners Pfizer Inc. and Germany's BioNTech:
Experts call Trump's rosy virus message misguided
Should people fear the coronavirus?